Lab Insights - Archives - Page 3 of 3 Sequencing

The evolution of liquid biopsy in EGFR testing for lung cancer

November 12, 2020

Over the last two decades, clinicians and laboratories gained greater understanding about genomic alterations in non-small cell lung cancer (NSCLC). With this wealth of knowledge comes the need for adapting protocols to optimise testing for disease diagnosis and treatment. In this recent webinar collaboration between AstraZeneca and Roche Diagnostics Asia Pacific, Dr Chih-Hsi Kuo, director […]

The evolution of liquid biopsy in EGFR testing for lung cancer Read More »

EGFR testing in lung cancer: 2020 updates from Dr Noemi Reguart

October 29, 2020

EGFR testing in lung cancer diagnostics: 2020 updates from Dr Noemi Reguart

Mortality rates for patients with non-small-cell lung carcinoma (NSCLC) dropped sharply in 2020 following the approval of a number of drugs targeting the EGFR mutation, which is common in Asian patient populations. In this recent webinar, Dr Noemi Reguart, a medical oncologist at the Hospital Clinic in Barcelona, stresses the importance of using biomarker testing

EGFR testing in lung cancer: 2020 updates from Dr Noemi Reguart Read More »

Next-generation sequencing (NGS) drives precision oncology in Singapore

August 27, 2020

This article is part of a series of case studies on the use of NGS and digital tools to drive precision oncology in the Asia Pacific region. Scroll to the bottom of the article for the full list. Over the last half-century, the study of gene and molecular alterations has been transformed by the replacement

Next-generation sequencing (NGS) drives precision oncology in Singapore Read More »

Updated evidence and implementation models of cfDNA testing

May 8, 2019

Full presentation by Prof Liona Poon delivered to clinicians at the 2018 NIPT Forum Asia held in Bangkok, Thailand.

Updated evidence and implementation models of cfDNA testing Read More »

The evolution of non-invasive prenatal test technologies

April 30, 2019

Prenatal visits are generally happy occasions, but many women still experience some anxiety as every pregnancy comes with a risk of chromosomal abnormalities. Fortunately, advances in non-invasive prenatal test technologies (NIPT) make the testing process more convenient and reliable than ever before. The Rise of cfDNA Analysis for NIPT Since its introduction in the 1990s,

The evolution of non-invasive prenatal test technologies Read More »

ctDNA provides new confidence in fight against China’s deadliest cancer

April 30, 2019

ctDNA provides new confidence in China's lung cancer diagnostics

Lung cancer is the most common cancer in China [1] and the most deadly. Unlike in many Western countries, the number of lung cancer diagnoses is also continuing to rise. By harnessing ctDNA technology, we have an opportunity to significantly improve patient care and outcomes. Traditionally to confirm a cancer diagnosis, a suspected cancerous tumour is biopsied and

ctDNA provides new confidence in fight against China’s deadliest cancer Read More »